Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome

Pediatric Nephrology

Volumn 26, Issue 10, 2011, Pages 1823-1828

  Ito, Shuichi ^a   Kamei, Koichi ^a   Ogura, Masao ^a   Sato, Mai ^a   Fujimaru, Takuya ^a   Ishikawa, Tomoaki ^a   Udagawa, Tomohiro ^a   Iijima, Kazumoto ^b  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Children; Mycophenolate mofetil; Nephrotic syndrome; Rituximab; Steroid dependent

Indexed keywords

CD20 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID;

ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG INFUSION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INJECTION SITE DISCOMFORT; MAINTENANCE THERAPY; MALE; NEPHROTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; RELAPSE; SCHOOL CHILD; SINGLE DRUG DOSE; SORE THROAT; STEROID THERAPY; TREATMENT DURATION;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; PILOT PROJECTS; PREDNISOLONE; PROSPECTIVE STUDIES; RECURRENCE; STEROIDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052288964     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1886-x     Document Type: Article

References (17)

1. K Benz J Dötsch W Rascher D Stachel 2004 Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy Pediatr Nephrol 19 794 797 15071769 10.1007/s00467-004-1434-z (Pubitemid 38931165)
2. K Nozu K Iijima M Fujisawa A Nakagawa N Yoshikawa M Matsuo 2005 Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome Pediatr Nephrol 20 1660 1663 16133051 10.1007/s00467-005-2013-7 (Pubitemid 41554486)
3. K Kamei S Ito K Nozu S Fujinaga M Nakayama M Sako M Saito M Yoneko K Iijima 2009 Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children Pediatr Nephrol 24 1321 1328 19421786 10.1007/s00467-009- 1191-0
4. S Fujinaga D Hirano N Nishizaki K Kamei S Ito Y Ohtomo T Shimizu K Kaneko 2010 Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine Pediatr Nephrol 25 539 544 20049616 10.1007/s00467-009-1377-5
5. V Guigonis A Dallocchio V Baudouin M Dehennault C Hachon-Le Camus M Afanetti J Groothoff B Llanas P Niaudet H Nivet N Raynaud S Taque P Ronco F Bouissou 2008 Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases Pediatr Nephrol 23 1269 1279 18465150 10.1007/s00467-008-0814-1
6. (1981) The primary nephrotic syndrome in children: identification of patients with minimal change nephrotic syndrome from initial response to prednisone - a report of the International Study of Kidney Disease in Children. J Pediatr 98:561-564
7. AL Sellier-Leclerc MA Macher C Loirat V Guérin H Watier M Peuchmaur V Baudouin G Deschênes 2010 Rituximab efficiency in children with steroid-dependent nephrotic syndrome Pediatr Nephrol 25 1109 1115 20238230 10.1007/s00467-010-1465-6
8. HA Kyrieleis MM Löwik I Pronk HR Cruysberg JA Kremer WJ Oyen BL van den Heuvel JF Wetzels EN Levtchenko 2009 Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children Clin J Am Soc Nephrol 4 1593 1600 19808243 10.2215/CJN.05691108
9. RS Trompeter PR Evans TM Barratt 1981 Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods Lancet 30 1177 1179 10.1016/S0140-6736(81)92348-5 (Pubitemid 11102736)
10. RJ Hogg L Fitzgibbons J Bruick M Bunke B Ault N Baqi H Trachtman R Swinford 2006 Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group Clin J Am Soc Nephrol 1 1173 1178 17699344 1:CAS:528:DC%2BD28Xht1GntbzF 10.2215/CJN.00550206
11. S Fujinaga Y Ohtomo D Umino M Takemoto T Shimizu Y Yamashiro K Kaneko 2007 A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome Pediatr Nephrol 22 71 76 17086405 10.1007/s00467-006-0294-0 (Pubitemid 46138363)
12. EM Dorresteijn JE Kist-van Holthe EN Levtchenko J Nauta WC Hop AJ van der Heijden 2008 Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome Pediatr Nephrol 23 2013 2020 18622632 10.1007/s00467-008-0899-6
13. AP Sharma G Filler 2009 Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab Pediatr Nephrol 24 423 424 18853197 10.1007/s00467-008-1030-8
14. K Iijima K Hamahira R Tanaka A Kobayashi K Nozu H Nakamura N Yoshikawa 2002 Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome Kidney Int 61 1801 1805 11967030 10.1046/j.1523-1755.2002.00303.x (Pubitemid 34437934)
15. KR Carson AM Evens EA Richey TM Habermann D Focosi JF Seymour J Laubach SD Bawn LI Gordon JN Winter RR Furman JM Vose AD Zelenetz R Mamtani DW Raisch GW Dorshimer ST Rosen K Muro NR Gottardi-Littell RL Talley O Sartor D Green EO Major CL Bennett 2009 Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project Blood 113 4834 4840 19264918 1:CAS:528:DC%2BD1MXmslalsbw%3D 10.1182/blood-2008-10-186999
16. M Bitzan M Anselmo L Carpineta 2009 Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature Pediatr Pulmonol 44 922 934 19681063 10.1002/ppul.20864
17. MC Chaumais A Garnier F Chalard M Peuchmaur S Dauger E Jacqz-Agrain G Deschênes 2009 Fatal pulmonary fibrosis after rituximab administration Pediatr Nephrol 24 1753 1755 19396468 10.1007/s00467-009-1195-9